Niitaka (4465) Q1 2025 earnings summary

Executive summary

• Revenue/net sales rose 4.1% year-over-year to ¥5,733 million for the first quarter ended August 31, 2024.

• Operating income increased 47.4% to ¥426 million, with ordinary income up 45.1% to ¥440 million.

• Net income attributable to parent shareholders surged 49.3% to ¥296 million, with EPS at ¥50.24, up from ¥33.66.

• Profit growth was driven by higher detergent and solid fuel sales, cost reductions, and subsidiary contributions.

• Comprehensive income increased to ¥364 million from ¥277 million year-over-year.

Financial highlights

• Gross profit improved to ¥2,113 million from ¥1,935 million year-over-year.

• Selling, general and administrative expenses rose slightly to ¥1,687 million.

• Total assets remained stable at ¥22,741 million as of August 31, 2024.

• Net assets increased to ¥13,619 million, with an equity ratio of 59.9%.

• Cost of sales ratio improved to 63.1% from 64.9% year-over-year.

Outlook and guidance

• Full-year net sales forecasted at ¥23,500 million, up 3.3% year-over-year.

• Operating profit projected at ¥1,500 million, ordinary profit at ¥1,530 million, and profit attributable to owners of parent at ¥1,000 million (up 41.7%).

• Full-year earnings per share expected to reach ¥169.39.

• Annual dividend forecast raised to ¥52.00 per share.

• Infection prevention product sales remain at 1.5 times pre-pandemic levels, indicating sustained demand.

• Management notes that forecasts are based on currently available information and reasonable assumptions but are subject to risks and uncertainties.